The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127896551 12789655 1 I 20150824 20160921 20160928 20160928 EXP JP-MYLANLABS-2016M1040959 MYLAN 0.00 Y 0.00000 20160928 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127896551 12789655 1 PS Cilostazol MYLAN CILOSTAZOL 1 Oral 50 MG, BID D 77019 50 MG TABLET BID
127896551 12789655 2 SS Magnesium Oxide MYLAN MAGNESIUM OXIDE 1 Oral 500 MG, BID D 0 500 MG TABLET BID
127896551 12789655 3 SS ELIQUIS APIXABAN 1 Oral 2.5 MG, BID D 0 2.5 MG TABLET BID
127896551 12789655 4 SS ELIQUIS APIXABAN 1 D 0 TABLET
127896551 12789655 5 SS AMLODIPINE AMLODIPINE BESYLATE 1 Oral 5 MG, QD D 0 5 MG TABLET QD
127896551 12789655 6 SS MECOBALAMIN METHYLCOBALAMIN 1 Oral 500 ?G, TID D 0 500 UG TABLET TID
127896551 12789655 7 SS LIMAPROST ALFADEX LIMAPROST 1 Oral 5 ?G, TID D 0 5 UG TABLET TID
127896551 12789655 8 SS AZOSEMIDE AZOSEMIDE 1 Oral 15 MG, QD D 0 15 MG TABLET QD
127896551 12789655 9 SS ALLOPURINOL. ALLOPURINOL 1 Oral 100 MG, BID D 0 100 MG TABLET BID
127896551 12789655 10 SS PREGABALIN. PREGABALIN 1 Oral 150 MG, BID D 0 150 MG CAPSULE BID
127896551 12789655 11 SS WARFARIN POTASSIUM WARFARIN POTASSIUM 1 Oral 2 MG, QD D 0 2 MG TABLET QD
127896551 12789655 12 SS WARFARIN POTASSIUM WARFARIN POTASSIUM 1 Oral 2 MG, QD D 0 2 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127896551 12789655 1 Lumbar spinal stenosis
127896551 12789655 2 Constipation
127896551 12789655 3 Ischaemic stroke
127896551 12789655 4 Embolism
127896551 12789655 5 Hypertension
127896551 12789655 6 Lumbar spinal stenosis
127896551 12789655 7 Lumbar spinal stenosis
127896551 12789655 8 Oedema
127896551 12789655 9 Hyperuricaemia
127896551 12789655 10 Lumbar spinal stenosis
127896551 12789655 11 Atrial fibrillation

Outcome of event

Event ID CASEID OUTC COD
127896551 12789655 OT
127896551 12789655 DE
127896551 12789655 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127896551 12789655 Cardiac failure congestive
127896551 12789655 Cardiac valve disease
127896551 12789655 Ear haemorrhage
127896551 12789655 Haematemesis
127896551 12789655 Haemorrhagic diathesis
127896551 12789655 Heart valve stenosis
127896551 12789655 International normalised ratio increased
127896551 12789655 Interstitial lung disease
127896551 12789655 Right ventricular failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127896551 12789655 3 20151001 0
127896551 12789655 11 20150924 0
127896551 12789655 12 20151001 0